Oct 31, 2016 12:01 pm UTC| Business
Data Underscore Potential of SVP-Rapamycin to Improve Therapeutic Benefit and Tolerability by Mitigating Unwanted Human Immune ResponsesResults Presented at the Immunogenicity and Bioassay Summit WATERTOWN, Mass., Oct. ...
Oct 31, 2016 12:01 pm UTC| Business
NEW YORK, Oct. 31, 2016 -- Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) today announced presentation (in oral and poster forms) of results from its clinical development program in schizophrenia that has replicated the...
Oct 31, 2016 12:01 pm UTC| Business
NEW YORK, Oct. 31, 2016 -- Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) today announced presentation (in oral and poster forms) of results from its clinical development program in schizophrenia that has replicated the...
TESARO Announces Presentation of Niraparib Data at the 2016 IGCS Biennial Meeting
Oct 31, 2016 12:01 pm UTC| Business
WALTHAM, Mass., Oct. 31, 2016 -- TESARO, Inc. (NASDAQ:TSRO), an oncology-focused biopharmaceutical company, today announced the presentation of data from the ENGOT-OV16/NOVA trial of niraparib at the 2016 International...
Oct 31, 2016 12:00 pm UTC| Business
MALVERN, Pa., Oct. 31, 2016 -- Aclaris Therapeutics, Inc. (NASDAQ:ACRS), today announced that it has submitted an Investigational New Drug Application (IND) to the U.S. Food and Drug Administration (FDA) for its drug...
Oct 31, 2016 12:00 pm UTC| Business
SOUTH SAN FRANCISCO, Calif., Oct. 31, 2016 -- Portola Pharmaceuticals, Inc.® (Nasdaq:PTLA) announced today that it will host a webcast and conference call to discuss the Company’s financial results for the quarter ended...
Oct 31, 2016 12:00 pm UTC| Business
EMERYVILLE, Calif., Oct. 31, 2016 -- Zogenix, Inc. (NASDAQ:ZGNX), a pharmaceutical company developing therapies for the treatment of orphan and central nervous system (CNS) disorders, today announced that it will report...